Several cancer research organizations and Owkin, a company specializing in artificial intelligence (AI) are collaborating to map cancer cell… Read more
Allogeneic (allo) cell therapies offer substantial benefits to patients due to their efficacy and availability. However, giving patients access to… Read more
Value-based care models have been put forward as a solution for rising Medicare costs, paying providers for the value their care provides patients.… Read more
Shortly following the end of the COVID-19 public health emergency, pandemic-era restrictions on Medicaid redetermination ended. In that time, over… Read more
A newly published study in JAMA Health Forum found that new Medicare Part D price caps on out-of-pocket prescription drug costs will help new… Read more
Cityblock Health has raised $400 million in its latest funding round. This brings the value of the startup to a whopping $5.7 billion. The company… Read more
The EU Commission has approved the Novavax COVID-19 vaccine booster for adults 18 and above. The move comes only weeks after the European Medicine… Read more
Artificial intelligence (AI) and machine learning (ML) has seen increasing implantation into medtech solutions in recent years, driven by advances in… Read more
Glaxo-Smith Klein (GSK) has received approval by the European Commission for its respiratory syncytial virus (RSV) vaccine Arexvy in adults aged 60… Read more
Amid growing scrutiny of pharmacy benefit managers (PBMs) at the public and congressional level, a PBM industry group has launched an ad campaign… Read more
Real-world evidence (RWE) is a key part of a successful product launch or indication expansion, but doing so requires a careful strategy to maximize… Read more